A1M Pharma has strengthened its management with the appointment of Martin Austin as Business Development Director. Martin Austin has 35 years of experience in the pharmaceutical industry, focusing on financing, strategy and business development. He has been a Board member of A1M Pharma since March 2015 and will take up his position with immediate effect.

Martin joins as A1M Pharma maintains strong progress in its development projects focusing on diagnostics and treatment of pre-eclampsia, and treatment of acute kidney injury.